Skip to main content
Fig. 2 | Journal of Medical Case Reports

Fig. 2

From: Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report

Fig. 2

a Changes in tumor markers (CEA, CA19-9 and CA125), CBC, and CRP. b Changes in liver function, serum albumin, renal fanction and electrolytes. CEA Carcinoembryonic antigen (U/ml), CA19-9 Cancer antigen 19-9 (U/ml), CA125 Cancer antigen 125 (U/ml), WBC White blood cell count (× 100 per cubic milliliter), Neut Neutrophil (× 100 per cubic milliliter), Hg Hemoglobin (g/dl), PLT Platelet count (× 10,000 per cubic milliliter), CRP C-reactive protein (mg/L), T-Bil Total bilirubin (mg/dl), AST Aspartate transaminase (IU/L), ALT Alanine transaminase (IU/L), ALP Alkaline phosphatase (IU/L), Alb Albumin (g/dl), BUN Blood urea nitrogen (mg/dl), CRE Creatinine (mg/dl), Na Sodium (mEq/L), Cl Chloride (mEq/L), P Potassium (mEq/L)

Back to article page